OIG reprimands NIH for not enforcing trial transparency requirements

Regulatory News

Regulatory NewsFerdous Al-Faruque

BiologicsBiotechnologyClinical TrialsCombination ProductsComplianceDiagnosticsMedical DevicesNorth AmericaOtherPharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and Development